Total pharmaceutical sales in Sweden during February–October 2009 were EUR 2,127 (2,268) million in pharmacy purchase prices (PPP). In local currency, this represents an increase of 2.8% compared to the same period in the previous year.
Tamro Sweden’s net sales during February–October were EUR 1,096 (1,149) million. In local currency, the sales increased by 7.6% due to a major new supplier contract. The company’s average market share in wholesale was 55%. Tamro Sweden employed an average of 457 (462) people.
The operating environment in Sweden changed significantly when the pharmacy market de-regulation came into effect in July 2009. Tamro decided not to make a final bid in the sale of the pharmacy clusters and is now considering its strategic alternatives and adjusting its business model to the reformed pharmaceutical market. The market adaptation will incur some costs for Tamro Sweden during the rest of the year.
